Publications by authors named "Alessandra Balduzzi"

Claim this Profile
I
Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study.
Alessandra Balduzzi, Vincenzo Bagnardi, Maria Teresa Sandri, Silvia Dellapasqua, Anna Cardillo

Clin Breast Cancer· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonrandomized comparison between concomitant and sequential chemoradiotherapy with anthracyclines in breast cancer.
Maria Cristina Leonardi, Anna Morra, Luigi Santoro, Alessandra Balduzzi, Giovanni Battista Ivaldi

Tumori· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
Alessandra Balduzzi, Vincenzo Bagnardi, Nicole Rotmensz, Silvia Dellapasqua, Emilia Montagna

Clin Breast Cancer· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases.
Silvia Dellapasqua, Vincenzo Bagnardi, Alessandra Balduzzi, Monica Iorfida, Nicole Rotmensz

Clin Breast Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.
Emilia Montagna, Patrick Maisonneuve, Nicole Rotmensz, Giuseppe Cancello, Monica Iorfida, Alessandra Balduzzi

Clin Breast Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab.
Silvia Dellapasqua, Vincenzo Bagnardi, Francesco Bertolini, Maria Teresa Sandri, Davide Pastrello, Alessandra Balduzzi

Breast· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features.
Emilia Montagna, Vincenzo Bagnardi, Nicole Rotmensz, Giuseppe Viale, Giancarlo Pruneri, Alessandra Balduzzi

Breast Cancer Res Treat· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer.
Rosalba Torrisi, Anna Cardillo, Giuseppe Cancello, Silvia Dellapasqua, Alessandra Balduzzi

Clin Breast Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Laura Bonmassar, Emanuela Fossile, Alessandro Scoppola, Grazia Graziani, Salvatore P Prete, Alessandra Balduzzi

Anticancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy.
Alessandra Balduzzi, Maria Cristina Leonardi, Anna Cardillo, Roberto Orecchia, Silvia Dellapasqua

Cancer Treat Rev· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer.
Monica Iorfida, Vincenzo Bagnardi, Alessandra Balduzzi, Silvia Dellapasqua, Anna Cardillo

Breast· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
Alessandra Balduzzi, Emilia Montagna, Vincenzo Bagnardi, Rosalba Torrisi, Francesco Bertolini

Anticancer Drugs· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative concurrent chemo- and endocrine therapies for women with large operable breast cancer expressing steroid hormone receptors.
Rosalba Torrisi, Silvia Dellapasqua, Raffaella Ghisini, Giuseppe Viale, Paolo Veronesi, Alessandra Balduzzi

Breast· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.
Claudia D'Alessandro, Silvia Dellapasqua, Laura Orlando, Luigi Santoro, Patrick Maisonneuve, Alessandra Balduzzi

Breast J· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer.
Laura Orlando, Barbara Del Curto, Sara Gandini, Raffaella Ghisini, Elisabetta Pietri, Alessandra Balduzzi

Breast· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
Rosalba Torrisi, Alessandra Balduzzi, Raffaella Ghisini, Andrea Rocca, Luca Bottiglieri

Cancer Chemother Pharmacol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
Andrea Rocca, Giuseppe Viale, Richard D Gelber, Luca Bottiglieri, Shari Gelber, Alessandra Balduzzi

Cancer Chemother Pharmacol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter.
Giuseppe Curigliano, Alessandra Balduzzi, Anna Cardillo, Raffaella Ghisini, Giulia Peruzzotti

Support Care Cancer· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCG-infected adherent mononuclear cells release cytokines that regulate group 1 CD1 molecule expression.
Salvatore Pasquale Prete, Anna Giuliani, Stefania D'Atri, Grazia Graziani, Alessandra Balduzzi

Int Immunopharmacol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
Laura Orlando, Anna Cardillo, Andrea Rocca, Alessandra Balduzzi, Raffaella Ghisini

Anticancer Drugs· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Laura Orlando, Anna Cardillo, Raffaella Ghisini, Andrea Rocca, Alessandra Balduzzi

BMC Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia risk after adjuvant treatment of early breast cancer.
Alessandra Balduzzi, Monica Castiglione-Gertsch

Womens Health (Lond)· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor.
Lucio Tentori, Ilaria Portarena, Marcella Barbarino, Alessandra Balduzzi, Lauretta Levati

Mol Pharmacol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of peripheral blood with staurosporine increases detection of circulating carcinoembryonic antigen positive tumor cells.
Angelo Aquino, Salvatore Pasquale Prete, Alessandra Balduzzi, Vincenzo Formica, Emanuela Fossile

Int J Cancer· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis